Latest News
LivaNova secures higher Medicare reimbursement for VNS Therapy procedures
24 November 2025 - Medical technology company LivaNova PLC (Nasdaq: LIVN) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) will assign VNS Therapy for drug-resistant epilepsy (DRE) new patient implants to New Technology Ambu...
Tonix Pharmaceuticals receives FDA clearance for Phase 2 study of major depressive disorder treatment
24 November 2025 - US biotechnology company Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) announced on Monday that the US Food and Drug Administration has cleared its Investigational New Drug application for TNX-102 SL in adults with major depre...
AstraZeneca to invest USD2bn in major Maryland manufacturing expansion
24 November 2025 - AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) declared on Monday that it will invest USD2bn to expand its manufacturing footprint in Maryland, adding capacity at its Frederick biologics plant and building a new clinical manuf...
Enlivex Therapeutics reports sustained six-month efficacy for Allocetra in Phase IIa knee osteoarthritis trial
24 November 2025 - Israeli clinical-stage immunotherapy developer Enlivex Therapeutics Ltd. (NASDAQ: ENLV), on Monday reported positive six-month efficacy results from the Phase IIa segment of its multi-country Phase I/II Allocetra trial in moderate ...
Riyadh's 10th SPNS Conference Focuses on AI and Technology as Catalysts for Better Paediatric Neurology Care
24 November 2025 - * Riyadh has welcomed 600 paediatric neurology experts and specialists from around the world for the 10th Saudi Pediatric Neurology Society (SPNS) Conference, an event dedicated to sharing expertise, strengthening collaboration, an...